HPS-149 - Efficacy of transarterial chemoembolization combined with tyrosine kinase inhibitors for hepatocellular carcinoma: A systematic review and meta-analysis

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-149
• By: WENG, Yi Fang (Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, China Taiwan)
• Co-author(s): Ms Yi Fang Weng (Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, China Taiwan)
  Ms Tzu Rong Peng (Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, China Taiwan)
  Ms Pei Ying Hsieh (Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, China Taiwan)
  
• Abstract:

  Introduction
  Transcatheter arterial chemoembolization (TACE) is widely used as first-line therapy for unresectable hepatocellular carcinoma (HCC). Nevertheless, the limited efficacy of TACE is still considered as a challenge due to high reoccurrence rate of HCC after TACE therapy. Multiple tyrosine kinase inhibitors (TKIs) have been showed the..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login